Best Value Based Oncology Podcasts (2025)

1
Precision, speed, impact: Evolving mass spectrometry for medical science 19:22

4d ago19:22

19:22

Originally employed in atomic physics, mass spectrometry is now an indispensable tool in modern science, and importantly medical science. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Melissa Sherman, CEO of MOBILion Systems, a company pioneering next-generation separation science, by innovating best-in-class instruments that …

1
IMUNON at ASCO 2025: Changing the micro-tumour environment in advanced ovarian cancer 14:14

6d ago14:14

14:14

Onsite at ASCO 2025 in Chicago, web editor Nicole Raleigh sat down with Dr Stacy Lindborg, CEO of IMUNON, to discuss the company’s oral presentation at the Congress from the Phase 2 OVATION 2 study of IMNN-001, an IL-12 immunotherapy, in women with newly diagnosed advanced ovarian cancer – since published in the peer-reviewed journal Gynecologic On…

1
Episode 155: Dr. Sean McMillan, D.O.- Orthopedic Surgeon and President of the AOAO, Do you know what it takes to do Ortho? Soon you will! 30:22

6d ago30:22

30:22

Send us a text Today we will interview Sean McMilan, the president of the AOAO, which stands for the American Osteopathic Academy of Orthopedics. He will discuss why he feels orthopedics is a great specialty and what being a DO brings to the profession. He will talk about his own difficult journey and how he pays it forward, helping Osteopathic Phy…

1
Treating primary bone cancer: The potential of listeria-based bioengineered bacterial immunotherapy 18:37

10d ago18:37

18:37

Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and high recurrence rates. It mostly affects children and young adults under 20 years of age. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Paul Romness, president and CEO of OS The…

1
Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treatment with Tibsovo & Voranigo 9:25

18d ago9:25

9:25

At ASCO 2025, Servier presented data in the IDH-mutated cancer space. Onsite at McCormick Place in Chicago, pharmaphorum web editor Nicole Raleigh spoke with Becky Martin, chief US medical at Servier about the key data from the company’s Tibsovo and Voranigo programmes, as well as the implications for patients and the wider themes of the Congress t…

1
Where innovation meets collaboration: Live from Manchester’s City labs 4.0 38:15

18d ago38:15

38:15

In healthcare, some of the most meaningful innovations happen when the right people are brought together in the right place. True progress depends on systems and infrastructure designed to connect ideas, people, and expertise across sectors. Citylabs 4.0, now open in the heart of Manchester’s Knowledge Quarter on the Oxford Road Corridor, was built…

1
Live from ASCO 2025: Boehringer Ingelheim on unmet needs and oncology innovation 9:57

19d ago9:57

9:57

Boehringer Ingelheim’s data presented at ASCO 2025 reflected the company’s broad pipeline and growing body of evidence supporting innovative therapies for various cancers. In a pharmaphorum podcast recorded onsite at the Congress, web editor Nicole Raleigh spoke with Itziar Canamasas, global head of oncology at Boehringer Ingelheim, for a discussio…

1
Episode 154: Dr. Denise Wunderler, D.O.- Orthopedic Surgery Dropout? No way! Family Practice, Sports Med and Harley Davidson! Plus, the tragedy of SUDC. 51:22

20d ago51:22

51:22

Send us a text Dr Wunderler is a wonderful human being! She started her career as an Orthopedic Surgery resident but left when she found that the specialty was not for her. She loved sports and shifted gears going into Family Practice with an fellowship in sports medicine. She now works for Harley Davidson. . . A dream job! But there is a dark side…

1
Bringing patients to research centres: Using AI to bring efficiencies forward 19:07

23d ago19:07

19:07

Trends can be predicted, and trends can unfold. Here, Liz Beatty – co-founder and chief strategy of Inato – speaks to the beginnings of a new era in drug development brought on by key technological advances in AI. Historically, large urban academic centres have conducted the majority of clinical trials, leading to such issues as inaccessibility, la…

1
The need for a science-first mindset: The vaccine landscape today 19:34

1M ago19:34

19:34

As has been widely reported on, immunisation rates, including for flu and RSV, have been falling – at a troubling rate – and diseases like whooping cough and measles have seen a worrying resurgence due to anti-vaxxers. And not just in the US. In a new pharmaphorum podcast, Rebecca Catterick, General Manager for Vaccines, UK & Ireland, at Sanofi, di…

1
Episode 153: Dr. Olutayo Sogunro, D.O. From Trauma Surgery to Breast Surgery! Saving Lives and changing outcomes! 1:02:57

1M ago1:02:57

1:02:57

Send us a text A member of the Board of Governors for the American College of Osteopathic Surgeons, Dr. Sogunro feels that she was "born to be a D.O." She will share with us her journey from growing up in Africa, to moving to Connecticut at 13 with a dream of becoming a physican. When she became saddened as a trauma surgeon taking care of victims o…

1
EAPs: Market access outside of the US and Western Europe 13:36

1M ago13:36

13:36

Early access programmes (EAPs) for novel medicines are an often-misunderstood strategy outside of western markets. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Cem Zorlular, CEO of Er-Kim Pharmaceuticals, a company that has been serving as a regional affiliate for pharma and biotech since 1981 in the CEE and Mediterranean. M…

1
The value of a partner, globally and locally 22:08

1M ago22:08

22:08

With the FDA and EMA releasing their annual reports detailing novel drug approvals in 2024, a new pharmaphorum podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face in the year ahead. Host Nicole Raleigh is joined by Cencora’s Sandra Anderson, SVP of Internationa…

1
The ins and outs of HEOR – A lever for global health 24:56

2M ago24:56

24:56

ISPOR 2025, the leading global conference for Health Economics and Outcomes Research (HEOR), takes place 13th-16th May and marks the 30th anniversary of the organisation. Ahead of the event, web editor Nicole Raleigh spoke with Rob Abbott, CEO and executive director of ISPOR – the leading professional society for HEOR globally – about the ins and o…

1
Episode 152: Dr. Anna Levy, D.O. - Hematology/ Oncology- Director of Hepato-billiary Malignancies at NorthWell Health! 40:20

2M ago40:20

40:20

Send us a text In today's episode we have the pleasure of speaking to Dr. Anna Levy, D.O. Dr. Levy is an oncologist who works in the very specialized area of liver related cancers. Dr. Levy is Medical Director of Hepatobiliary Malignancies and the Hepatic Artery Pump Infusion Program, based at the R.J. Zuckerberg Cancer Center. Dr Levy is is Board …

1
Unpacking Trumps executive order on drug pricing with Alice Valder Curran 26:23

2M ago26:23

26:23

President Donald Trump’s April 15th executive order, “Lowering Drug Prices by Once Again Putting Americans First”, contained a smorgasbord of policy proposals targeting a variety of industry stakeholders. But how much legal force do these different elements have, and what are the concrete takeaways for pharma? To answer these questions and more, ho…

1
AI in drug development: The real hurdle is implementation 12:05

2M ago12:05

12:05

It can take up to 15 years for a new drug to reach the market, and with only 20% of pharmaceutical professionals adopting AI, one thing is clear: innovation in drug development is lagging behind. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about how the real hurdle…

1
Patients as active consumers of care: AI-driven personalisation in pharma marketing 24:02

2M ago24:02

24:02

Therapy initiation, adherence, and health outcomes are being driven by artificial intelligence (AI)-powered personalisation. Today’s consumers are more active participants in their healthcare. Marketing in the era of consumer-driven healthcare requires new strategies to reach patients with the information they require, and how and when they need it…

1
Driving the drug discovery pipeline: The value of organ-on-a-chip MPS 18:42

2M ago18:42

18:42

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostriezewski, CSO at CN Bio, about single organ-on-a-chip technology and multi-organ microphysiological systems (MPS), as well as accelerating drug discovery pipelines with these new alternative methodologies (NAMs). Clinical trial success rates are very low, with up to 95…

1
Episode 151: Dr. Shandra Basil, D.O.- Are there Difficulties with Family Practice? Have you considered Direct Primary Care? Is this model the answer? 57:36

2M ago57:36

57:36

Send us a text Direct Primary Care or DPC is a model of medicine that has been around for well over decade. It has become a growing movement of passionate physicians focusing on restoring the physician patient relationship and providing excellent healthcare at an affordable price. It gives patient’s direct access to their doctor, as well as an appr…

1
Intelligent regulatory compliance and improved patient outcomes 15:10

2M ago15:10

15:10

Across the life sciences, Regulatory Affairs (RA) teams and their colleagues in Quality and Safety are stretched beyond their limits as already impossible demands on their time are compounded by rising health authority expectations. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Sonia A. Veluchamy, CEO and co-founder of Celege…

1
Prevention for a healthier, more productive society 15:13

2M ago15:13

15:13

In a new pharmaphorum podcast, recorded during Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh spoke with David Gillen, chief medical officer at Norgine, about the role of prevention in the future of healthcare. Recorded onsite at The Eden Project in Cornwall, the conversation centred around the Adelphi Group-sponsored panel, ‘The Preve…

1
Episode 150: Dr. Lisa Warren, D.O. Dean- Western University of Health Sciences- Triumphs and Hardships! 49:20

3M ago49:20

49:20

Send us a text This week, we are joined by Dr. Lisa Warren, Dean of Western University of Health Sciences, COMP and COMP-Northwest. Dr. Warren discusses the unique student experiences across the dual campuses and Western U’s commitment to preparing students for future healthcare challenges. She emphasizes the importance of humanism, collaboration, …

1
Safeguarding the pharmaceutical supply chain 13:37

3M ago13:37

13:37

As we hear of the volcanic and seismic activity taking place in Iceland this week, pharmaphorum turns back to a conversation with Dean Alms, CPO of Aravo, on how extreme weather highlights the need to make adequate supply chain preparations for the seasons in which the planet pulls out all the stops with the worst of its natural disasters. Having a…

1
For the continuum of mental health we need a whole system, holistic 'healthspan' 35:49

3M ago35:49

35:49

If we don’t address the mental health of young people, that mental health challenge will advance into the adult population of tomorrow. What can be done to address the issue, though? At Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh sat down with Dr Sebastian Vaughn, CEO of Phytome Life Sciences, for an en plein air and explorative con…

1
Episode 149: Dr. GinaMarie Papia, D.O.: Integrative Medicine in the modern era! What is that?? 33:14

3M ago33:14

33:14

Send us a text This week, we are joined by Dr. Ginamarie Papia, a remarkable physician whose journey spans from her studies at Lake Erie College of Osteopathic Medicine to her current practice in integrative medicine. With a deep commitment to both traditional and complementary approaches, Ginamarie has seamlessly integrated her passion for patient…

1
IRA updates and making sense of the chaos in Washington, with Alice Valder Curran 38:29

3M ago38:29

38:29

Last year, Alice Valder Curran, a partner at Hogan Lovells and a healthcare policy expert in Washington, D.C. joined host Jonah Comstock on the pharmaphorum podcast to talk about the intended and unintended consequences of the drug pricing negotiation provisions in the Inflation Reduction Act. On today’s episode, Curran joins us once again for an u…

1
Episode 148: Dr. Kris Belland, D.O.- Aerospace Medicine and Medical Errors- Never say "Whoops" in the OR! and what it's like to fly an F-14 Tomcat! 42:21

3M ago42:21

42:21

Send us a text Today, we’re thrilled to welcome Dr. Chris Belland, D.O., a retired Navy flight surgeon and the first osteopathic physician to serve as president of the Aerospace Medical Association. Dr. Belland was recommended by Dr. Hauler and the American Osteopathic association who together are spearheading an effort to educate physicians about …

1
GenAI and the revolution of drug development 11:05

4M ago11:05

11:05

It takes around seven years to develop a new drug and bring it to market. With the advent of GenAI, businesses in the life sciences sector can speed up the process, wiping months or even years off that average. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Bryan Hill, life sciences chief technology officer at Cognizant, in a …

1
Patient-focused manufacturing models for personalised therapies 22:44

4M ago22:44

22:44

Unique, patient-focused manufacturing models are needed to scale up innovative cell therapies for cancer and one company, CTMC, is challenging the status quo to achieve this and get them to patients. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jason Bock, co-founder and CEO of CTMC, a first-of-its-kind cell therapy engine a…

1
On specialty pharmacies and prior authorisations 18:13

4M ago18:13

18:13

Prior authorisations (or PAs) have long put a burden on pharmacy and medical practices, ultimately causing delays for patients. In a new podcast, web editor Nicole Raleigh speaks with Andrew Burns, chief revenue officer at DrFirst, about the ramifications of delayed patient care when it comes to specialty medications. Exploring the current PA lands…

1
Episode 147: D.O. Myths and Misconceptions 3: Osteopathic Manipulation is a Placebo? No Science? NOT! C.O.R.K.: The Conference on Osteopathic Research and Knowledge- Evidence based OMM 42:28

4M ago42:28

42:28

Send us a text This is our third episode in a Series called M and M , or Myths and Misconceptions about Osteopathic Medicine. Today we will tackle the sentiment that “Osteopathic Manual Medicine is Voodoo.” Typically this is based on the fact that the scientific evidence behind the modality is limited. I want to start by sharing with our listeners …

1
Paediatric rare diseases: Children are not small adults 16:56

4M ago16:56

16:56

Around 75% of rare diseases are diagnosed in childhood, with most before the age of two. With 30% of rare disease patients dying before the age of five, the need for different treatment methods for children is clear. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Helen Thackray, chief R&D officer at biotech company BioCryst…

1
Defining, building, and implementing in the next wave of biopharma R&D 25:27

4M ago25:27

25:27

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with two PharmaLex experts about navigating complex R&D processes to unleash the next wave of biopharma breakthroughs. PharmaLex’s Dr Christian Schneider, VP & Chief Medical Officer, Clinical Development Services, together with Dr Christelle Boileau, Director of Regulatory Development …

1
Episode 146: Josh Baker, D.O., PhD- Why would you do a PhD!? The Value of the Dual Degree! Plus why Michigan State University- COM? 46:32

4M ago46:32

46:32

Send us a text We are always excited when listeners reach out to us to share their story. Today, we're excited to speak with Josh Baker, a DO/PhD student at the Michigan State University College of Osteopathic Medicine. Josh will explain the path that a clinician scientist can take, the importance of scientific research and what Osteopathic Medicin…

1
Insights from JP Morgan Healthcare 2025: Key trends shaping the pharma industry 1:04:49

5M ago1:04:49

1:04:49

The JP Morgan Healthcare Conference remains one of the most influential events for the life sciences sector, setting the stage for major deal-making, investment trends, and strategic shifts that will define the year ahead. Keen to capture all the key trends and talking points from this year’s event, pharmaphorum editor-in-chief, Jonah Comstock, hit…

1
‘Show me the molecule’ – On synthetic biology and cutting through AI hype 15:01

5M ago15:01

15:01

Therapeutic antibodies are a vital weapon in combating diseases such as cancer, but developing these treatments through conventional methods is slow and unreliable. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Dr James Field, founder and CEO of LabGenius, a drug discovery company pioneering the discovery of next-generation th…

1
Simulated clinical trial populations and AI scalability 29:03

5M ago29:03

29:03

AI might still be in the modish buzzword stage, but discussions exploring the potential for its scaling within life sciences are critical. In a new pharmaphorum podcast with ZS Associates’ Sharon Karlsberg, principal and leader of oncology solutions, and Brandi Davis-Dusenbery, principal and partner, web editor Nicole Raleigh explores the potential…

1
Episode 145: Dr. Michael Ayoub, D.O.- Tales from the Dark Side- NO Match? NO Soap? A New HOPE! 52:15

5M ago52:15

52:15

Send us a text Michael Ayoub was an Osteopathic Medical students with great expectations. . . and then some difficulty passing a test called the COMLEX created a speed bump. He didn't Match, he didn't SOAP. . . so what could he do? Michael kept his chin up and took a job as a medical assistant with a pain management physician and tried again . . . …

1
Rare disease and the women's health gap 15:43

5M ago15:43

15:43

For women with rare diseases, they often face a double jeopardy, where many of the symptoms they experience can be confused with and misdiagnosed as menopause. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jennifer Schranz, head of rare diseases at Ipsen, for a conversation focused on rare liver disease primary biliary cholan…

1
From science fiction to reality: AI in drug development 21:32

5M ago21:32

21:32

With about 92% of new drugs failing in human clinical trials, pharma companies face tremendous financial losses and, more importantly, development and delivery of potentially life-saving treatments are woefully delayed. In today’s pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Isaac Bentwich, CEO and founder of Quris.AI, about how A…

1
Episode 144: Dr. Richard Terry, D.O.- Premed Highlight- LECOM Middletown Dean: Classic Ideas with a New Perspective 25:14

5M ago25:14

25:14

Send us a text Today, we’re joined by Dr. Richard Terry, D.O., a family medicine physician and founding dean of Lake Erie College of Osteopathic Medicine (LECOM) Elmira campus, who also holds the title of Assistant Dean of Regional Clinical Education. Dr. Terry shares how LECOM started the branch campus system and highlights the New York- Elmira ca…

1
Episode 143: Dr. Christopher Fullmer D.O.- Integrated Plastic Surgery Resident- Can a DO match into a competitive surgical residency? You bet your Tram flap! Crossover from the Physicians Mind 42:38

6M ago42:38

42:38

Send us a text Today’s episode is a crossover episode of an interview with Chris fullmer, a plastic surgery resident at Penn State. To start, our listeners should know that for plastic surgery there are two paths, the traditional which includes application to general surgery followed by a second match into a plastic surgery fellowship and a newer p…

1
Precision medicine, NGS, and the quantum leap in biomarkers 23:30

6M ago23:30

23:30

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company committed to advancing precision medicine, for a conversation on this space and a new frontier of biomarkers. Quagliata discusses Thermo Fisher’s ongoing collabo…

1
Episode 142: Dr. Nicholas Elwert, D.O.- PM & R; Neuro-Rehab in Kentucky plus Residency Matching Pearls! 35:26

6M ago35:26

35:26

Send us a text Today, we have a special guest, Dr. Nicholas Elwert, DO, MS, who wears many hats in the field of Physical Medicine & Rehabilitation (PM&R). Dr. Elwert is an Assistant Professor at the University of Kentucky, where he also serves as the Stroke Rehabilitation Program Director and Associate Residency Program Director. With a deep passio…

1
Seeking effective, safe treatment for all with precision dosing 31:14

6M ago31:14

31:14

In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Dr Victoria Richon, CEO of Entact Bio, a company focused on the small molecule space, with its team of scientists, entrepreneurs, drug creators, and problem solvers working together to bring new medicines to patients who currently have few options. Creating new medicines by e…

1
Seeking effective, safe treatment for all with precision dosing 16:48

7M ago16:48

16:48

Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that recognises biological individuality – especially when it comes to paediatric care. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Sharmeen Roy, chief scientist at DoseMe, for a conversation on precision medi…

1
Episode 141: Dr. Rebecca Levy-Gantt, D.O. - OB/GYN- Womb With a View and other tales from Wine Country! 46:27

7M ago46:27

46:27

Send us a text We love when amazing Osteopathic Physicians reach out to us to be on the Podcast! Today we interview Dr. Levy-Gantt, A board certified OB/GYN who practices in Napa Valley! She will speak to us about how she manages a solo practice in California and her work as an author. Dr. Gantt will discuss her journey from physical therapy into m…

1
CAR-T therapies: Faster, better, cheaper 17:56

7M ago17:56

17:56

In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics. Working in the in vivo cell therapy space, Johnson discusses the injection of a manufactured vector into a patient to create the CAR-T cells directly inside the body of the patient, without the need for chemothe…

1
Looking to history to prepare for America’s uncertain future 18:21

7M ago18:21

18:21

Since the results of the US election, the news has been awash with what the future might hold under a second Trump Administration, particularly within healthcare and life sciences. In today’s podcast, web editor Nicole Raleigh is joined by Jesse Mendelsohn, senior vice president of Model N’s Center of Excellence, for a conversation that explores mu…

Podcasts Worth a Listen

Value Based Oncology Podcasts

Podcasts Worth a Listen

Quick Reference Guide